Pressure Ulcer Market Forecast: Anticipated Growth and Key Insights by 2032

To support these companies in the development of effective treatments for pressure ulcers, DelveInsight has released a comprehensive report titled “Pressure Ulcer Market Insight: Epidemiology and Market Forecast, 2032.” This report offers in-depth epidemiology-based market analysis, serving as a strategic roadmap for stakeholders navigating the complexities of the pressure ulcer market.

Key Highlights from the Pressure Ulcer Market Report

The pressure ulcer market is projected to grow significantly across the seven major markets (7MM) during the study period.
The report identifies key players in the market, including Phagelux, MiMedx, EyeGene, Shionogi, NovaLead Pharma, Smith & Nephew PLC, Integra LifeSciences Holding Corporation, Baxter International Inc. (Hill-Rom Holdings Inc.), Molnlycke Health Care AB, Cardinal Health, Essity Aktiebolag, 3M Company, B. Braun Melsungen AG, ConvaTec Group PLC, and Coloplast Group.
There is a notable correlation between diabetes and pressure ulcer incidence, with approximately 537 million adults living with diabetes in the 7MM, of whom around 150 million may suffer from ulcers at some point in their lives.
In the United States, it is estimated that 10% of the population will experience pressure ulcers at some point in their lifetime.
The market is expected to surge due to the increasing prevalence of pressure ulcers and rising awareness, alongside the introduction of various pipeline products aimed at addressing this condition.

Get a free sample of “Pressure Ulcer Market Report”

Epidemiological Insights and Treatment Analysis

The report provides valuable insights into the treatment regimens across the 7MM, allowing companies to analyze current practices, the patient journey, and recent advances in pressure ulcer therapies. Understanding these factors is crucial for identifying opportunities to enhance treatment paradigms and improve patient outcomes.

Pressure ulcers, often referred to as bedsores or pressure sores, are localized injuries to the skin and underlying tissue resulting from prolonged pressure. They commonly develop in individuals who are bedridden, use wheelchairs, or have limited mobility, typically forming over bony areas such as the heels, hips, tailbone, and elbows. Various factors, including pressure intensity, duration, and overall health, influence the development of these ulcers.

Future Market Dynamics and Opportunities

The report details a thorough analysis of past and projected markets for pressure ulcers, highlighting expected changes driven by emerging therapies such as Thymosin Beta 4, Ibuprofen, and others during the forecast period (2019-2032). The increasing prevalence of pressure ulcers, less competition for upcoming therapies, and a shift in focus among companies toward this area are key drivers fueling market growth.

DelveInsight's report offers comprehensive insights, market analysis, and forecasts to aid leading companies in making strategic decisions regarding their position within the pressure ulcer market landscape.

Get a free sample of “Pressure Ulcer Market Report”

Strategic Planning and Decision Making

With insights derived from epidemiological trends and market forecasts, stakeholders can make informed decisions regarding research and development investments, portfolio expansion, pricing strategies, partnerships, and other strategic initiatives. By understanding the dynamics of the pressure ulcer market, stakeholders can align their goals with prevailing trends and future projections, ensuring a robust roadmap for success.

About DelveInsight

DelveInsight is a premier healthcare business consultant and market research firm focused exclusively on life sciences. The firm supports pharmaceutical companies by providing comprehensive end-to-end solutions to enhance performance and offers healthcare consulting services to facilitate market analysis, thereby accelerating business growth and overcoming challenges with practical strategies.

Latest Reports